Correlation Between Reviva Pharmaceuticals and Humacyte
Can any of the company-specific risk be diversified away by investing in both Reviva Pharmaceuticals and Humacyte at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Reviva Pharmaceuticals and Humacyte into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Reviva Pharmaceuticals Holdings and Humacyte, you can compare the effects of market volatilities on Reviva Pharmaceuticals and Humacyte and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Reviva Pharmaceuticals with a short position of Humacyte. Check out your portfolio center. Please also check ongoing floating volatility patterns of Reviva Pharmaceuticals and Humacyte.
Diversification Opportunities for Reviva Pharmaceuticals and Humacyte
-0.5 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Reviva and Humacyte is -0.5. Overlapping area represents the amount of risk that can be diversified away by holding Reviva Pharmaceuticals Holding and Humacyte in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Humacyte and Reviva Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Reviva Pharmaceuticals Holdings are associated (or correlated) with Humacyte. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Humacyte has no effect on the direction of Reviva Pharmaceuticals i.e., Reviva Pharmaceuticals and Humacyte go up and down completely randomly.
Pair Corralation between Reviva Pharmaceuticals and Humacyte
Assuming the 90 days horizon Reviva Pharmaceuticals Holdings is expected to generate 5.21 times more return on investment than Humacyte. However, Reviva Pharmaceuticals is 5.21 times more volatile than Humacyte. It trades about 0.05 of its potential returns per unit of risk. Humacyte is currently generating about 0.06 per unit of risk. If you would invest 98.00 in Reviva Pharmaceuticals Holdings on August 29, 2024 and sell it today you would lose (75.00) from holding Reviva Pharmaceuticals Holdings or give up 76.53% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 91.73% |
| Values | Daily Returns |
Reviva Pharmaceuticals Holding vs. Humacyte
Performance |
| Timeline |
| Reviva Pharmaceuticals |
| Humacyte |
Reviva Pharmaceuticals and Humacyte Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Reviva Pharmaceuticals and Humacyte
The main advantage of trading using opposite Reviva Pharmaceuticals and Humacyte positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Reviva Pharmaceuticals position performs unexpectedly, Humacyte can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Humacyte will offset losses from the drop in Humacyte's long position.| Reviva Pharmaceuticals vs. Reviva Pharmaceuticals Holdings | Reviva Pharmaceuticals vs. CannBioRx Life Sciences | Reviva Pharmaceuticals vs. Clene Inc | Reviva Pharmaceuticals vs. Lixte Biotechnology Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Complementary Tools
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |